Code 285.22 is for use for anemia that is due to the malignancy, not for anemia due to antineoplastic chemotherapy drugs, which is an adverse effect. See I.C.2.c.1 Anemia associated with malignancy. See I.C.2.c.2 Anemia associated with chemotherapy, immunotherapy and radiation therapy. ...